Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.
Petroni D, Bégin P, Bird JA, Brown-Whitehorn T, Chong HJ, Fleischer DM, Gagnon R, Jones SM, Leonard S, Makhija MM, Oriel RC, Shreffler WG, Sindher SB, Sussman GL, Yang WH, Bee KJ, Bois T, Campbell DE, Green TD, Rutault K, Sampson HA, Wood RA. Petroni D, et al. Among authors: sussman gl. JAMA Pediatr. 2024 Apr 1;178(4):345-353. doi: 10.1001/jamapediatrics.2023.6630. JAMA Pediatr. 2024. PMID: 38407859 Free PMC article. Clinical Trial.
Pathophysiology of bradykinin and histamine mediated angioedema.
Lima H, Zheng J, Wong D, Waserman S, Sussman GL. Lima H, et al. Among authors: sussman gl. Front Allergy. 2023 Oct 18;4:1263432. doi: 10.3389/falgy.2023.1263432. eCollection 2023. Front Allergy. 2023. PMID: 37920409 Free PMC article. Review.
Relevance of lipid transfer protein to Cannabis sensitization in North America.
Morelli HP, Thorpe C, Ebo DG, Chapman MD, Abbas K, Sussman GL, Nayak AP. Morelli HP, et al. Among authors: sussman gl. J Allergy Clin Immunol Pract. 2023 Oct;11(10):3248-3249. doi: 10.1016/j.jaip.2023.06.039. Epub 2023 Jun 28. J Allergy Clin Immunol Pract. 2023. PMID: 37391020 No abstract available.
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Craig TJ, Reshef A, Li HH, Jacobs JS, Bernstein JA, Farkas H, Yang WH, Stroes ESG, Ohsawa I, Tachdjian R, Manning ME, Lumry WR, Saguer IM, Aygören-Pürsün E, Ritchie B, Sussman GL, Anderson J, Kawahata K, Suzuki Y, Staubach P, Treudler R, Feuersenger H, Glassman F, Jacobs I, Magerl M. Craig TJ, et al. Among authors: sussman gl. Lancet. 2023 Apr 1;401(10382):1079-1090. doi: 10.1016/S0140-6736(23)00350-1. Epub 2023 Feb 28. Lancet. 2023. PMID: 36868261 Clinical Trial.
Diphenhydramine: Time to Move on?
Wolfson AR, Wong D, Abrams EM, Waserman S, Sussman GL. Wolfson AR, et al. Among authors: sussman gl. J Allergy Clin Immunol Pract. 2022 Dec;10(12):3124-3130. doi: 10.1016/j.jaip.2022.07.018. Epub 2022 Aug 20. J Allergy Clin Immunol Pract. 2022. PMID: 35999169
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials.
Ciaccio C, Goldsobel AB, Anagnostou A, Beyer K, Casale TB, Deschildre A, Fernández-Rivas M, Hourihane JO, Krawiec M, Lieberman J, Scurlock AM, Vickery BP, Smith A, Tilles SA, Adelman DC, Brown KR; RAMSES (ARC007) and ARC011 Study Groups:. Ciaccio C, et al. Ann Allergy Asthma Immunol. 2022 Dec;129(6):758-768.e4. doi: 10.1016/j.anai.2022.07.033. Epub 2022 Aug 13. Ann Allergy Asthma Immunol. 2022. PMID: 35973655 Free article. Clinical Trial.
Utilisation appropriée des antihistaminiques.
Chu DK, Oykhman P, Sussman GL. Chu DK, et al. Among authors: sussman gl. CMAJ. 2021 Jun 21;193(25):E992-E993. doi: 10.1503/cmaj.201959-f. CMAJ. 2021. PMID: 34155056 Free PMC article. French. No abstract available.
How to use antihistamines.
Chu DK, Oykhman P, Sussman GL. Chu DK, et al. Among authors: sussman gl. CMAJ. 2021 Apr 6;193(14):E478-E479. doi: 10.1503/cmaj.201959. CMAJ. 2021. PMID: 33824145 Free PMC article. No abstract available.
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
Vickery BP, Vereda A, Nilsson C, du Toit G, Shreffler WG, Burks AW, Jones SM, Fernández-Rivas M, Blümchen K, O'B Hourihane J, Beyer K, Anagnostou A, Assa'ad AH, Ben-Shoshan M, Bird JA, Carr TF, Carr WW, Casale TB, Chong HJ, Ciaccio CE, Dorsey MJ, Fineman SM, Fritz SB, Greiner AN, Greos LS, Hampel FC Jr, Ibáñez MD, Jeong DK, Johnston DT, Kachru R, Kim EH, Lanser BJ, Leonard SA, Maier MC, Mansfield LE, Muraro A, Ohayon JA, Oude Elberink JNG, Petroni DH, Pongracic JA, Portnoy JM, Rachid R, Rupp NT, Sanders GM, Sharma HP, Sharma V, Sher ER, Sher L, Sindher SB, Siri D, Spergel JM, Sprikkelman AB, Sussman GL, Tsoumani M, Varshney P, Vitalpur G, Wang J, Yang WH, Zubeldia JM, Smith A, Ryan R, Adelman DC. Vickery BP, et al. Among authors: sussman gl. J Allergy Clin Immunol Pract. 2021 May;9(5):1879-1889.e13. doi: 10.1016/j.jaip.2020.12.029. Epub 2020 Dec 24. J Allergy Clin Immunol Pract. 2021. PMID: 33359589 Free article. Clinical Trial.
83 results